Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: A potential physiologic basis for their mode of action

Journal of Lipid Research

Volumn 36, Issue 12, 1995, Pages 2541-2551

  Haubenwallner, S ^a   Essenburg, A D ^a   Barnett, B C ^a   Pape, M E ^a   DeMattos, R B ^a   Krause, B R ^a   Minton, L L ^a   Auerbach, B J ^a   Newton, R S ^a   Leff, T ^a   Bisgaier, C L ^a  

^a PFIZER INC   (United States)

Author keywords

apolipoprotein C II; apolipoprotein E; bezafibrate; clofibrate; coronary heart disease; fenofibrate; gemfibrozil; hepatic lipase; hypertriglyceridemia; lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BEZAFIBRATE; CLOFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HYPOLIPEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTILIPEMIC AGENTS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; BEZAFIBRATE; CHOLESTEROL; CLOFIBRATE; GEMFIBROZIL; LIVER; MALE; PROCETOFEN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRIGLYCERIDES;

EID: 0029610832     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)